Browse Category

Earnings Reports 30 November 2025

CRDO Stock Before December 1, 2025: Credo Technology’s AI Boom Faces Its Biggest Earnings Test

CRDO Stock Before December 1, 2025: Credo Technology’s AI Boom Faces Its Biggest Earnings Test

Credo Technology Group (CRDO) closed Friday at $177.60, up 8.3% on heavy volume, extending a rally that has lifted shares more than 138% year-to-date. The stock has returned about 1,174% over three years, outperforming all other U.S. semiconductor names. After-hours quotes edged higher ahead of Monday’s Q2 earnings report. CRDO’s 14-day RSI remains below overbought levels, leaving room for further moves.
Visa (V) Stock Outlook Before the December 1, 2025 Open: Q4 Earnings Beat, Stablecoin Push and Analyst Targets

Visa (V) Stock Outlook Before the December 1, 2025 Open: Q4 Earnings Beat, Stablecoin Push and Analyst Targets

Visa shares closed at $334.67 on November 28, about 11% below their 52-week high, valuing the company near $610 billion. The firm reported 12% revenue growth in fiscal Q4 and raised its quarterly dividend 14% to $0.67, payable December 1. Visa expanded stablecoin settlement in emerging markets and most analysts set 12-month price targets near $400. Some research firms warn of a stretched valuation.
Lululemon Athletica Inc (LULU) Stock on November 30, 2025: Deep‑Value Debate, Institutional Buying, and Key Risks Before Q3 Earnings

Lululemon Athletica Inc (LULU) Stock on November 30, 2025: Deep‑Value Debate, Institutional Buying, and Key Risks Before Q3 Earnings

Lululemon shares closed near $184 on November 28, 2025, down 42% from a year ago and more than 55% below their January peak. Groupama Asset Management increased its stake by 90% in Q2, while other funds also raised holdings. Institutional investors now own about 85% of the float. The stock trades at a P/E of roughly 12.5, with analysts split on its outlook.
30 November 2025
Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical shares closed at $573.48 on November 28, 2025, giving the company a market cap near $203.6 billion. Institutional investors hold about 89% of the float, with recent filings showing modest increases from firms like Grantham Mayo and Schroder. The stock is up roughly 30% from October lows after strong earnings, but has underperformed the Nasdaq Composite in some November periods. Analyst consensus remains “Moderate Buy.”
Lennar Stock (LEN): Exchange Offer Wraps, CEO Transition Looms as Wall Street Braces for Q4 2025 Earnings

Lennar Stock (LEN): Exchange Offer Wraps, CEO Transition Looms as Wall Street Braces for Q4 2025 Earnings

Lennar shares closed at $131.30 on November 28, down more than 20% from a recent 52-week high. The company completed an oversubscribed exchange offer, distributing 33.3 million Millrose Properties shares in return for 8 million Lennar shares. Major investors including Berkshire Hathaway have increased stakes, while Wall Street maintains a “Hold” rating. Lennar faces lower profit expectations and the retirement of Co-CEO Jon Jaffe.
Disney (DIS) Stock News Today, November 30, 2025: Q4 Earnings, Dividend Revival, YouTube TV Deal and New Legal Risks

Disney (DIS) Stock News Today, November 30, 2025: Q4 Earnings, Dividend Revival, YouTube TV Deal and New Legal Risks

Disney stock closed November 28 at $104.47, up 1% and about 16% below its June high. The company reported Q4 revenue of $22.5 billion, flat year-over-year, with GAAP EPS rising to $0.73 from $0.25. Full-year revenue reached $94.4 billion, up 3%. Disney also announced a $1.50 dividend and resumed buybacks.
Analog Devices (ADI) Stock Near Record Highs as Earnings Beat, Buybacks and Analyst Upgrades Drive Momentum — November 30, 2025

Analog Devices (ADI) Stock Near Record Highs as Earnings Beat, Buybacks and Analyst Upgrades Drive Momentum — November 30, 2025

Analog Devices shares closed near a 52-week high at $265.34 on November 30 after reporting fiscal Q4 revenue of $3.08 billion and EPS of $2.26, both above estimates. The stock jumped over 10% post-earnings, driven by a 17% annual revenue gain, raised analyst targets, and increased institutional buying. CFO is set to speak at the UBS Global Technology Conference on December 2.
Procter & Gamble (PG) Stock Outlook Today, November 30, 2025: Earnings Beat, Tariff Headwinds and Dividend Firepower

Procter & Gamble (PG) Stock Outlook Today, November 30, 2025: Earnings Beat, Tariff Headwinds and Dividend Firepower

Procter & Gamble shares closed at $148 on November 28, down 17% over the past year and near a 52-week low, despite an earnings beat and a rising dividend. Fiscal Q1 2026 net sales rose 3% to $22.4 billion; diluted EPS climbed 21% to $1.95. The company is cutting 7,000 jobs, exiting Pakistan, and faces new legal scrutiny of Crest brands. Management reaffirmed full-year guidance.
Zscaler (ZS) Stock After the Earnings Beat: November Sell-Off, Analyst Downgrades and 2026 Outlook

Zscaler (ZS) Stock After the Earnings Beat: November Sell-Off, Analyst Downgrades and 2026 Outlook

Zscaler shares closed at $251.50 on November 28, down about 24% for the month despite beating Q1 fiscal 2026 estimates and raising its outlook. Revenue rose 26% to $788.1 million, with non-GAAP net income at $159.5 million, or $0.96 per share. Market cap stands near $40 billion, about 25% below the 52-week high. Investors cited concerns over guidance and valuation.
ServiceNow (NOW) Stock on November 30, 2025: Q3 Beat, AI Push, 5‑for‑1 Split and $1 Billion Veza Rumors

ServiceNow (NOW) Stock on November 30, 2025: Q3 Beat, AI Push, 5‑for‑1 Split and $1 Billion Veza Rumors

ServiceNow shares closed at $812.41 on November 28, up 1.21% but still 32% below their January high. Q3 results showed revenue of $3.41 billion, up 22% year-over-year, and adjusted EPS of $4.82, beating estimates. Management raised 2025 guidance and announced a 5-for-1 stock split. The company is reportedly considering a $1+ billion cybersecurity acquisition.
Coherent Corp (COHR) Stock Surges on AI Demand and Earnings Beat: Latest News and Outlook as of November 30, 2025

Coherent Corp (COHR) Stock Surges on AI Demand and Earnings Beat: Latest News and Outlook as of November 30, 2025

Coherent Corp shares closed in the mid-$160s on November 28, up over 7% on heavy volume after a strong fiscal Q1 2026 earnings report and bullish analyst notes. The stock is near 52-week highs, up about 60% year-to-date and roughly 57% over the past year. Revenue for Q1 rose 17% to $1.58 billion, with GAAP EPS at $1.19. Pomerantz LLP has launched a shareholder investigation.
Uber Stock Update – November 30, 2025: How Earnings, Rating Upgrades, Robotaxis and Regulation Are Shaping UBER’s Next Move

Uber Stock Update – November 30, 2025: How Earnings, Rating Upgrades, Robotaxis and Regulation Are Shaping UBER’s Next Move

Uber shares closed at $87.54 on November 28, up 2.19%, giving the company a market cap near $182 billion. Third-quarter results showed $49.7 billion in gross bookings and $13.47 billion in revenue, both up over 20% year-on-year. S&P upgraded Uber’s credit outlook, but investors remain concerned about legal costs and new labor rulings affecting margins.
SoFi Technologies (SOFI) Stock on November 30, 2025: Crypto Push, Record Earnings and a Valuation Tug of War

SoFi Technologies (SOFI) Stock on November 30, 2025: Crypto Push, Record Earnings and a Valuation Tug of War

SoFi shares closed November 28 at $29.70, up 4% for the day and 17% for the week, with annual gains of over 260% reported earlier in the year. Q3 adjusted revenue reached $950 million, up 38% year over year, with net income at $139 million. The company raised its 2025 adjusted EPS guidance to $0.37. Trading volume remains below average as valuation debates intensify.
Salesforce (CRM) Stock Near 52‑Week Low as AI Jitters Collide With Big Data Bets Ahead of Q3 Earnings

Salesforce (CRM) Stock Near 52‑Week Low as AI Jitters Collide With Big Data Bets Ahead of Q3 Earnings

Salesforce closed at $230.54 on November 28, near its 52-week low and down 31% year-to-date, sharply underperforming the Dow Jones, which is up 5%. The company posted Q2 earnings above expectations but issued cautious revenue guidance, fueling investor concerns about slowing growth and uncertainty over AI’s impact on its business.
Marvell Technology (MRVL) Stock: UBS Lifts Target to $110 as Big-Money Buyers Crowd In Before Q3 Earnings

Marvell Technology (MRVL) Stock: UBS Lifts Target to $110 as Big-Money Buyers Crowd In Before Q3 Earnings

Marvell Technology closed at $89.40 on November 28, 2025, up 1.9% ahead of third-quarter earnings due December 2. Shares remain about 30% below their January peak despite a sharp rebound from mid-year lows. Q2 revenue hit a record $2.006 billion, up 58% year over year. Wall Street expects Q3 revenue near $2.06 billion and EPS of $0.74, driven by demand for custom AI chips and data center products.
Credo Technology Group (CRDO) Stock on November 30, 2025: Earnings Countdown, AI Connectivity Boom and Lofty Valuation

Credo Technology Group (CRDO) Stock on November 30, 2025: Earnings Countdown, AI Connectivity Boom and Lofty Valuation

Credo Technology Group (NASDAQ: CRDO) closed at $177.60 on November 30, 2025, up over 8% for the day and 423% since April. The company will report Q2 FY2026 earnings after the market closes on December 1, with Wall Street expecting around $235 million in revenue and EPS near $0.49. Analysts project triple-digit year-over-year growth. The stock’s 52-week range is $29.09 to $193.50.
CoreWeave Stock (CRWV) on November 30, 2025: 32% Post‑Earnings Slide, $55.6B Backlog and a Wall Street Split

CoreWeave Stock (CRWV) on November 30, 2025: 32% Post‑Earnings Slide, $55.6B Backlog and a Wall Street Split

CoreWeave shares closed at $73.12 on November 28, 2025, down over 60% from their 52-week high and more than 30% since Q3 earnings on November 10. The company reported record Q3 revenue and backlog but cut 2025 guidance and flagged a data center delay, triggering the sell-off. Market cap stands near $36 billion. Revenue for the trailing 12 months is about $4.3 billion, with a net loss of roughly $825 million.
Walmart Stock Near Record High After Earnings Beat, Nasdaq Switch and AI Push: Is WMT Still a Buy?

Walmart Stock Near Record High After Earnings Beat, Nasdaq Switch and AI Push: Is WMT Still a Buy?

Walmart stock hit a record high of $110.70 on Black Friday, following strong Q3 results and a move to Nasdaq. Fiscal Q3 revenue rose 5.8% to $179.5 billion, with U.S. e-commerce up 28% and global ad revenue up 53%. Shares have more than doubled in three years, outpacing the S&P 500. Walmart’s P/E ratio now stands near 41, above its 10-year median.
1 210 211 212 213 214 247

Stock Market Today

  • Cotton Prices Dip Amid Mixed Export Sales and Weaker Oil Markets
    May 14, 2026, 3:30 PM EDT. Cotton prices started August with losses ranging from 53 to 90 points on Thursday as outside markets provided little support. Crude oil fell 81 cents per barrel, while the dollar index rose 366 points. The USDA reported a significant 1.09 million running bales (RB) net reduction in old crop upland cotton sales for the week ending July 25, largely due to cancellations by China and Pakistan. These reductions were partly offset by new crop sales totaling 1.36 million RB. Shipments remained stable at nearly 130,000 RB. ICE cotton stocks declined by 1,982 bales after decertification, and the Cotlook A Index rose 25 points to 79.85 cents per pound on July 31. December 2024 cotton futures closed down 87 points at 68.12 cents per pound. The USDA's Average World Price for cotton was cut by 140 points to 55.02 cents.

Latest articles

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

14 May 2026
REGENXBIO shares fell 37% to $6.31 after its Duchenne muscular dystrophy gene therapy, RGX-202, met the main goal in a late-stage trial. Investors reacted to two serious adverse events and uncertainty over FDA approval. The company reported 93% of patients showed microdystrophin expression at 12 weeks. REGENXBIO said it will seek accelerated approval and targets a 2027 launch.
Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

14 May 2026
Digi Power X shares fell 14% to $7.28 in heavy trading Thursday ahead of its first-quarter results and operations update due May 15. Investors are focused on its $1.1 billion, 10-year AI data-center deal with Cerebras and a $19.6 million SubQ AI GPU rental contract launching Friday. The company also expanded its at-the-market share-sale program to $175 million.
Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

14 May 2026
Smart Powerr shares jumped to 78.83 cents, up nearly 59 cents from the previous close, after hitting 90.37 cents intraday. The surge followed news that Nasdaq warned the company over its sub-$1 share price and possible suspension. Trading volume reached about 395 million shares. The company said a hearing request would delay any suspension but gave no assurance of keeping its Nasdaq listing.
Go toTop